SG Americas Securities LLC Sells 192,479 Shares of ARK Genomic Revolution ETF (BATS:ARKG)

SG Americas Securities LLC lowered its position in ARK Genomic Revolution ETF (BATS:ARKG) by 86.1% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 31,087 shares of the company’s stock after selling 192,479 shares during the period. SG Americas Securities LLC owned 0.06% of ARK Genomic Revolution ETF worth $732,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ARKG. JPMorgan Chase & Co. lifted its position in shares of ARK Genomic Revolution ETF by 31.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,955,279 shares of the company’s stock valued at $75,655,000 after acquiring an additional 698,701 shares during the period. Atom Investors LP lifted its position in shares of ARK Genomic Revolution ETF by 15.2% during the 3rd quarter. Atom Investors LP now owns 49,131 shares of the company’s stock valued at $1,258,000 after acquiring an additional 6,496 shares during the period. Barclays PLC lifted its position in shares of ARK Genomic Revolution ETF by 252.7% during the 3rd quarter. Barclays PLC now owns 285,108 shares of the company’s stock valued at $7,299,000 after acquiring an additional 204,283 shares during the period. Elmwood Wealth Management Inc. lifted its position in shares of ARK Genomic Revolution ETF by 39.7% during the 3rd quarter. Elmwood Wealth Management Inc. now owns 57,766 shares of the company’s stock valued at $1,479,000 after acquiring an additional 16,412 shares during the period. Finally, National Bank of Canada FI lifted its position in shares of ARK Genomic Revolution ETF by 28.4% during the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after acquiring an additional 920 shares during the period.

ARK Genomic Revolution ETF Stock Performance

ARK Genomic Revolution ETF stock opened at $26.26 on Thursday. The company’s 50-day moving average is $25.10 and its two-hundred day moving average is $25.18.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.